6
Participants
Start Date
June 14, 2016
Primary Completion Date
May 22, 2017
Study Completion Date
May 22, 2017
Revlimid
Revlimid was used with dexamethasone to treat patients with multiple myeloma
Velcade
Velcade was a proteasome inhibitor indicated for treatment of patients with multiple myeloma
dexamethasone
Dexamethasone was a steroid used to treat patients with multiple myeloma.
Farydak
FARYDAK® (panobinostat) capsules was a prescription medicine used, in combination with bortezomib and dexamethasone, to treat adults with a type of cancer called multiple myeloma after at least 2 other types of treatment have been tried.
Northside Hospital Central Research Dept., Atlanta
Memorial West Cancer Center Memorial Cancer Institute, Pembroke Pines
Oncology Hematology West Nebraska Cancer Specialists dbaNebraska Cancer Specialists, Omaha
Brooke Army Medical Center Hematology/Oncology, San Antonio
David Geffen School of Medicine at UCLA UCLA, Los Angeles
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY